In September, Neuralink received the Food and Drug Administration’s blessing to fast-track its vision technology, called ...

In September, Neuralink Corp. received the Food and Drug Administration’s blessing to fast-track its vision technology, ...

Neuralink, Elon Musk’s brain-implant company, aims to bring sight back to those who have lost it, even from birth. The company’s groundbreaking device, known as “Blindsight,” promises to ...

Neuralink’s visual prosthesis Blindsight has been designated a breakthrough device by the U.S. Food and Drug Administration, which potentially sets the technology on a fast track to approval. In ...

Elon Musk's Neuralink has been awarded breakthrough status from the FDA for an implantable chip – dubbed Blindsight – that promises to restore the sight of people with vision impairment.

In September, Neuralink received a "breakthrough device" designation from the Food and Drug Administration for its "Blindsight" brain implant, which Elon Musk claims — without evidence — will ...

The US Food and Drug Administration (FDA) has awarded a "Breakthrough Device" status to Neuralink’s experimental vision-restoring implant, Blindsight. This designation is intended to fast-track ...

Noland Arbaugh and Alex, both quadriplegic individuals, made history as the first participants in Neuralink's human trials of the N1 Implant, enabling them to control devices with their thoughts.

Things are looking a little brighter now. In September, Neuralink received a "breakthrough device" designation from the Food ...